According to Aileron Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.86. In 2022 the company made an earnings per share (EPS) of -$6.04 a decrease over its 2021 EPS that were of -$5.69.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.86 | -52.65% |
2022 | -$6.04 | 6.15% |
2021 | -$5.69 | -54.84% |
2020 | -$12.60 | -50.78% |
2019 | -$25.60 | -40.19% |
2018 | -$42.80 | -82.47% |
2017 | -$244.15 | 632.19% |
2016 | -$33.34 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -23.78% | ๐บ๐ธ USA |